checkAd

     121  0 Kommentare Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency

    SK Life Science, Inc. uses modern cloud solution to accelerate validation processes for increased inspection readiness

    BARCELONA, Spain, Jan. 11, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co. Ltd., a global biotech company, is using Veeva Vault Validation Management to streamline and accelerate their validation process. By adopting a validation solution with built-in best practices, the company can execute digital validation while centralizing data and improving visibility.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Veeva Systems A!
    Short
    217,75€
    Basispreis
    1,49
    Ask
    × 12,77
    Hebel
    Long
    188,26€
    Basispreis
    1,58
    Ask
    × 11,96
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Veeva Systems

    "As the industry continues to shift from traditional paper-based validation, more companies are advancing validation with Veeva Vault Validation Management to streamline and standardize processes," said Nina Ricciardelli, director, Veeva Vault Validation Management. "SK Life Science, Inc. is a prime example of one of those forward-thinking companies modernizing validation for greater efficiency and speed."

    SK Life Science, Inc., an innovative pharmaceutical company committed to accelerating the development of next-generation treatments for central nervous system (CNS) disorders and cancer care, adopted Vault Validation Management to further support its team with digital collaboration, standardized processes and workflows, and simpler test execution. The company is building off its success with Veeva Vault QualityDocs and Veeva Vault QMS to optimize its validation programs, driving greater compliance and traceability across all systems. Shifting to a digital approach provides the transparency necessary to identify trends and proactively address potential issues, reducing compliance risks.

    "Veeva Vault Validation Management allows us to further simplify our validation process for significant cost and time-savings in test execution," said Hina Patel, vice president and global head of quality assurance, SK Life Science, Inc. "Using an advanced validation solution helps improve our efficiency, data integrity, and audit readiness."

    Additional Information
    For more on Veeva Vault Validation Management, visit: veeva.com/eu/VaultValidationManagement Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

    About Veeva Systems
    Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

    Veeva Forward-looking Statements
    This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2023, which you can find here (a summary of risks which may impact our business can be found on pages 38 and 39), and in our subsequent SEC filings, which you can access at sec.gov.

    Contact:



    Jeremy Whittaker
    Veeva Systems
    +49-695-095-5486
    jeremy.whittaker@veeva.com


    Deivis Mercado
    Veeva Systems
    925-226-8821
    deivis.mercado@veeva.com

     

    Logo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/leading-pharma-adopts-veeva-vault-validation-management-for-digital-validation-execution-and-improved-efficiency-302031721.html


    The Veeva Systems Registered (A) Stock at the time of publication of the news with a raise of +0,17 % to 177,1EUR on Tradegate stock exchange (11. Januar 2024, 10:42 Uhr).


    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency SK Life Science, Inc. uses modern cloud solution to accelerate validation processes for increased inspection readiness BARCELONA, Spain, Jan. 11, 2024 /PRNewswire/ - Veeva Systems (NYSE: VEEV) today announced that SK Life Science, Inc., a subsidiary …

    Artikel zu den Werten

    Schreibe Deinen Kommentar

    Disclaimer